Latest Breaking News On - Hepeng shi - Page 1 : comparemela.com

Avistone Biotechnology Closes Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesHepeng shiNational medical products administrationAvistone biotechnologyYanchuang capitalBain capital

Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI

BEIJING, China (BUSINESS WIRE) Avistone Biotechnology Co., Ltd (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, today announced results from its China and US IND enabling nonclinical studies for ANS014004 (“ANS01”), a novel small-molecule type II c-M.

United statesHepeng shiEuropean organisation for researchAvistone biotechnology co ltdAvistone biotechnology coAmerican association for cancer researchNational cancer instituteAmerican associationCancer researchEuropean organisationMassachusetts united

Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHepeng shiAvistone biotechnology co ltdEuropean organisation for researchAvistone biotechnology coNational cancer instituteAmerican association for cancer researchAmerican associationCancer researchEuropean organisationMassachusetts united

Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital

Press release content from Business Wire. The AP news staff was not involved in its creation.

Hong kongPalo altoUnited statesShan fuJun gaoScott lessneRicky sunDavid liuKatera mujadidiJiaqi zhengHongbo luHepeng shiChina national medical products administrationBain capital life sciencesPearl biotechnology coInvestor group

Vivo Capital, Bain Back Chinese Biotech Firm in $200 Million Fundraising

Chinese biotechnology firm Avistone Pharmaceuticals has raised over $200 million in a series A round led by Vivo Capital in one of the largest such deals for the sector.

United statesHong kongPalo altoHongbo luHepeng shiAvistone pharmaceuticalsZai lab ltdPearl biotechnology coSinovac biotech ltdBolt biotherapeutics incVivo capitalBain capitalPrimavera capitalBeijing based avistonePearl biotechnologyGreater china